** Healthcare services co Healius HLS.AX announces high single-digit EBIT margin target for FY27, exceeding estimates of Citi and Jefferies
** Market might maintain healthy level of scepticism about this target given previous false starts and valuation that is still relatively high, Citi says
** Jefferies notes potential for significant EBIT uplift, but says it will update its forecasts in line with delivery of these targets
** Jefferies also sees green shoots in Australian healthcare services and hopes HLS can benefit from this
** Citi maintains its target price at A$1.05 and rating at "neutral"; Jefferies raises target price from A$1.45 to A$1.65, keep "hold" rating
** Stock up 5.8% YTD
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com; X: @thatstanishk;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.